Article

Robert W. Dubois, MD, PhD, Describes the Initial Expectations of Accountable Care Organizations

Conference|AMCP: The Academy of Managed Care Pharmacy

Robert W. Dubois, MD, PhD, the chief science officer of the National Pharmaceutical Council discusses the initial expectations of implementing accountable care organizations (ACOs) and how those expectations have evolved over time.

Robert W. Dubois, MD, PhD, the chief science officer of the National Pharmaceutical Council discusses the initial expectations of implementing accountable care organizations (ACOs) and how those expectations have evolved over time.

This video was taken at the Academy of Managed Care Pharmacy's 25th Annual Meeting & Expo in San Diego, CA, on April 4, 2013.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!
Related Videos
Dr Marina Kremskayana
Dr Sundar Jagannath
Marla Black Morgan, MD, Phoebe Neurology Associates
Martin Engelke
David Awad, PharmD, BCOP
Dr Adela Perolla
Dr Adela Perolla | Image Credit: - stock.adobe.com
Dr Ola Landgren
Dr Ola Landgren
Andrew Kuykendall, MD, Moffitt Cancer Center
Related Content
taxes Image Credit - maxsim - stock.adobe.com
June 13th 2025

Is the Employer Health Care Tax Exclusion Safe? Kerris Willis Shares Insight From American Benefits Council

Giuliana Grossi
While the tax exclusion for employer-sponsored health care was not included in the House-passed reconciliation bill, it remains a revenue target for Congress, risking inclusion in the Senate's version.
managed care cast logo
June 10th 2025

Blister Packs May Help Solve Medication Adherence Challenges and Lower Health Care Costs

Brooke McCormick Julia D. Lucaci, PharmD, MS
Julia Lucaci, PharmD, MS, of Becton, Dickinson and Company, discusses the benefits of blister packaging for chronic medications, advocating for payer incentives to boost medication adherence and improve health outcomes.
Microscope slides for laboratory research | Image Credit: © Kirsten D:peopleimages.com - stock.adobe.com
June 13th 2025

Measurable Residual Disease in Decision-Making: An Opportunity, but Not a Promise

Christina Mattina
Skepticism still persists around the use of measurable residual disease (MRD) for clinical and regulatory decision-making in the European context, but panelists explained the next steps that are required to advance the use of MRD.
AJMC Managed Care Cast
December 31st 2024

AJMC® Editors Reflect on 2024 and Look Forward to a Milestone

Christina Mattina
The editors in chief of The American Journal of Managed Care® discuss the key managed care research and news from 2024 and look forward to the journal’s upcoming 30th anniversary.
AJMC
June 12th 2025

How Value-Based Care With Provider Enablement Improves Maternal and Infant Outcomes in Medicaid

Benjamin Howell, PhD, MPP Leah Ramirez, MS Kristin Austin, MPH Sara Varner, MPH Bryony Winn, MPhil Tiffany Inglis, MD
Supported value-based care improves prenatal care while reducing neonatal intensive care unit stays, preterm birth rates, low birth weight rates, and costs for mothers and infants.
Lymphoma | Image credit: Dr_Microbe - stock.adobe.com
June 12th 2025

Epcoritamab Improves Outcomes, HRQOL in Patients With Relapsed/Refractory Follicular Lymphoma

Julia Bonavitacola
Both monotherapy and combination therapy containing epcoritamab had high response rates and survival benefits when compared with usual care.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo